跳至主要内容
临床试验/NCT04692935
NCT04692935Unknown不适用

Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis

Jun Wang0 个研究点目标入组 450 人开始时间: 2021年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
450
主要终点
Oncoprint of somatic mutations

研究概览

简要总结

Lung adenocarcinomas (LUADs) from Asian ancestry are reported to have different genomic architectures compared with LUADs from Caucasian ancestry. However, due to lack of available cases, few studies controlled the clinical attributes during the comparisons of the genomic alterations. In this study, the investigators will identify Asian LUADs patients who had broad-panel next-generation sequencing (NGS) performed on their primary tumor between January 2018 and December 2019 at the department of thoracic surgery of Peking University People's Hospital. Then, Caucasian LUADs patients who had targeted NGS (Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets [MSK-IMPACT]) will be identified in the GENIE database, which consists of 6673 primary lung adenocarcinoma samples with clinical annotations. Finally, genomic alterations regarding somatic mutations, copy number variations, fusions, mutational signatures, oncogenic pathways, and therapeutic actionability will be comprehensively compared between these two cohorts after adjusting age, sex, smoking status, and pathologic stage using propensity score matching. This study will elucidate important ancestry differences between Asian and Caucasian lung adenocarcinoma patients.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary lung adenocarcinoma
  • Broad-panel next-generation sequencing

排除标准

  • Inadequate clinicopathological information
  • Low-quality next-generation sequencing

结局指标

主要结局

Oncoprint of somatic mutations

时间窗: July 2021

Association between genomic features and race

Copy number variations (CNVs)

时间窗: July 2021

CNVs analysis by race

Mutational signatures

时间窗: August 2021

Analysis of mutational signatures by race

Oncogenic pathways

时间窗: September 2021

Analysis of oncogenic pathways by race

Therapeutic actionability

时间窗: October 2021

Analysis of actionable alterations by race

次要结局

未报告次要终点

研究者

发起方
Jun Wang
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jun Wang

Professor

Peking University People's Hospital

相似试验